The role of tissue inhibitors of metalloproteinases in microvascular endothelial cell barrier dysfunction during sepsis

References

• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801.
   PubMed Web of Science ®Google Scholar
• Genga KR, Russell JA. Update of sepsis in the intensive care unit. J Innate Immun. 2017;9(5):441–455.
   PubMed Web of Science ®Google Scholar
• Yende S, Austin S, Rhodes A, et al. Long-term quality of life among survivors of severe sepsis: analyses of two international trials. Crit Care Med. 2016;44(8):1461–1467.
   Web of Science ®Google Scholar
• Barichello T, Sayana P, Giridharan VV, et al. Long-term cognitive outcomes after sepsis: a translational systematic review. Mol Neurobiol. Epub 2018 Apr 23.
   Google Scholar
• Sagy M, Al-Qaqaa Y, Kim P. Definitions and pathophysiology of sepsis. Curr Probl Pediatr Adolesc Health Care. 2013;43(10):260–263.
   Web of Science ®Google Scholar
• Duque GA, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol. 2014;5:491.
   PubMed Web of Science ®Google Scholar
• Sullivan JS, Kilpatrick L, Costarino AT, Lee SC, Harris MC. Correlation of plasma cytokine elevations with mortality rate in children with sepsis. J Pediatr. 1992;120(4):510–515.
   Web of Science ®Google Scholar
• Nathan C, Ding A. Nonresolving inflammation. Cell. 2010;140(6):871–882.
   PubMed Web of Science ®Google Scholar
• Otto GP, Sossdorf M, Claus RA, et al. The late phase of sepsis is characterized by an increased microbiological burden and death rate. Critical Care. 2011;15(4):R183.
   PubMed Web of Science ®Google Scholar
• van Vught LA, Klein Klouwenberg PMC, Spitoni C, et al. Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. JAMA. 2016;315(14):1469.
   PubMed Web of Science ®Google Scholar
• Souza ACP, Yuen PST, Star RA. Microparticles: markers and mediators of sepsis-induced microvascular dysfunction, immunosuppression, and AKI. Kidney Int. 2015;87(6):1100–1108.
   Web of Science ®Google Scholar
• Wallez Y, Huber P. Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis. Biochim Biophys Acta. 2008;1778(3):794–809.
   PubMed Web of Science ®Google Scholar
• Bhattacharya J, Matthay MA. Regulation and repair of the alveolar-capillary barrier in acute lung injury. Annu Rev Physiol. 2013;75(1):593–615.
   PubMedGoogle Scholar
• Dejana E, Orsenigo F, Lampugnani MG. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci. 2008;121(13):2115–2122.
   PubMed Web of Science ®Google Scholar
• Weksler BB, Subileau EA, Perrière N, et al. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. Faseb J. 2005;19(13):1872–1874.
   PubMed Web of Science ®Google Scholar
• Anderson JM. Molecular structure of tight junctions and their role in epithelial transport. News Physiol Sci. 2001;16:126–130.
   PubMedGoogle Scholar
• Rodrigues SF, Granger DN. Blood cells and endothelial barrier function. Tissue Barriers. 2015;3(1–2):e978720.
   Google Scholar
• Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999;285(5430):1028–1033.
   PubMed Web of Science ®Google Scholar
• Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci. 2010;123(24):4195–4200.
   PubMed Web of Science ®Google Scholar
• Souza-Fernandes AB, Pelosi P, Rocco PRM. Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease. Critical Care. 2006;10(6):237.
   PubMed Web of Science ®Google Scholar
• Sukriti S, Tauseef M, Yazbeck P, Mehta D. Mechanisms regulating endothelial permeability. Pulm Circ. 2014;4(4):535–551.
   PubMed Web of Science ®Google Scholar
• Pober JS, Min W, Bradley JR. Mechanisms of endothelial dysfunction, injury, and death. Annu Rev Pathol Mech Dis. 2009;4(1):71–95.
   Google Scholar
• Lee KS, Jin SM, Kim HJ, Lee YC. Matrix metalloproteinase inhibitor regulates inflammatory cell migration by reducing ICAM-1 and VCAM-1 expression in a murine model of toluene diisocyanate-induced asthma. J Allergy Clin Immunol. 2003;111(6):1278–1284.
   Web of Science ®Google Scholar
• Kuebler WM, Wittenberg C, Lee WL, et al. Thrombin stimulates albumin transcytosis in lung microvascular endothelial cells via activation of acid sphingomyelinase. Am J Physiol Lung Cell Mol Physiol. 2016;310(8):L720–L732.
   Web of Science ®Google Scholar
• Wang L, Mehta S, Ahmed Y, Wallace S, Pape MC, Gill SE. Differential mechanisms of septic human pulmonary microvascular endothelial cell barrier dysfunction depending on the presence of neutrophils. Front Immunol. 2018;9:9.
   Web of Science ®Google Scholar
• Rahimi N. Defenders and challengers of endothelial barrier function. Front Immunol. 2017;8:1847.
   Web of Science ®Google Scholar
• Giannotta M, Trani M, Dejana E. VE-Cadherin and endothelial adherens junctions: active guardians of vascular integrity. Dev Cell. 2013;26(5):441–454.
   PubMed Web of Science ®Google Scholar
• Mehta D, Ravindran K, Kuebler WM. Novel regulators of endothelial barrier function. Am J Physiol Lung Cell Mol Physiol. 2014;307(12):L924–L935.
   PubMed Web of Science ®Google Scholar
• Dreymueller D, Uhlig S, Ludwig A. ADAM-family metalloproteinases in lung inflammation: potential therapeutic targets. Am J Physiol Lung Cell Mol Physiol. 2015;308(4):L325–L343.
   Web of Science ®Google Scholar
• Flemming S, Burkard N, Renschler M, et al. Soluble VE-cadherin is involved in endothelial barrier breakdown in systemic inflammation and sepsis. Cardiovasc Res. 2015;107(1):32–44.
   PubMed Web of Science ®Google Scholar
• Lakhan SE, Kirchgessner A, Tepper D, Leonard A, Aidan L. Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke. Front Neurol. 2013;4:32.
   PubMed Web of Science ®Google Scholar
• Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem. 1999;274(31):21491–21494.
   PubMed Web of Science ®Google Scholar
• Baker AH, Edwards DR, Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci. 2002;115(19):3719–3727.
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson WG. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest. 1999;103(9):1237–1241.
   Web of Science ®Google Scholar
• Dreymueller D, Pruessmeyer J, Groth E, Ludwig A. The role of ADAM-mediated shedding in vascular biology. Eur J Cell Biol. 2012;91(6–7):472–485.
   PubMed Web of Science ®Google Scholar
• Dreymueller D, Martin C, Kogel T, et al. Lung endothelial ADAM17 regulates the acute inflammatory response to lipopolysaccharide. EMBO Mol Med. 2012;4(5):412–423.
   Web of Science ®Google Scholar
• Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta – Mol Cell Res. 2010;1803(1):55–71.
   Google Scholar
• Masciantonio MG, Lee CKS, Arpino V, Mehta S, Gill SE. Chapter Three – the balance between metalloproteinases and TIMPs: critical regulator of microvascular endothelial cell function in health and disease. In: Khalil RABT. Matrix Metalloproteinases and Tissue Remodeling in Health and Disease: Cardiovascular Remodeling. Vol 147. Academic Press; 2017:101–131.
   Google Scholar
• Murphy G. Tissue inhibitors of metalloproteinases. Genome Biol. 2011;12(11):233.
   PubMed Web of Science ®Google Scholar
• Vaalamo M, Leivo T, Saarialho-Kere U. Differential expression of tissue inhibitors of metalloproteinases (TIMP-1, -2, -3, and -4) in normal and aberrant wound healing. Hum Pathol. 1999;30(7):795–802.
   PubMed Web of Science ®Google Scholar
• Ashcroft GS, Herrick SE, Tarnuzzer RW, Horan MA, Schultz GS, Ferguson MWJ. Human ageing impairs injury-inducedin vivo expression of tissue inhibitor of matrix metalloproteinases (TIMP)-1 and -2 proteins and mRNA. J Pathol. 1997;183(2):169–176.
   Web of Science ®Google Scholar
• Stetler-Stevenson WG. Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci Signal. 2008;1(27):re6.
   Web of Science ®Google Scholar
• Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69(3):562–573.
   PubMed Web of Science ®Google Scholar
• Johnson JL. Metalloproteinases in atherosclerosis. Eur J Pharmacol. 2017;816(June):93–106.
   Google Scholar
• Kelwick R, Desanlis I, Wheeler GN, Edwards DR. The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family. Genome Biol. 2015;16(1):113.
   PubMedGoogle Scholar
• Arpino V, Brock M, Gill SE. The role of TIMPs in regulation of extracellular matrix proteolysis. Matrix Biol. 2015;44–46:247–254.
   Web of Science ®Google Scholar
• Selman M, Ruiz V, Cabrera S. TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? Am J Physiol Cell Mol Physiol. 2000;279(3):L562–L574.
   PubMed Web of Science ®Google Scholar
• Elkington PTG, Friedland JS. Matrix metalloproteinases in destructive pulmonary pathology. Thorax. 2006;61(3):259–266.
   PubMed Web of Science ®Google Scholar
• Gill SE, Huizar I, Bench EM, et al. Tissue inhibitor of metalloproteinases 3 regulates resolution of inflammation following acute lung injury. Am J Pathol. 2010;176(1):64–73.
   PubMed Web of Science ®Google Scholar
• Akahane T, Akahane M, Shah A, Connor CM, Thorgeirsson UP. TIMP-1 inhibits microvascular endothelial cell migration by MMP-dependent and MMP-independent mechanisms. Exp Cell Res. 2004;301(2):158–167.
   Web of Science ®Google Scholar
• Chen P, Mcguire JK, Hackman RC, et al. Tissue inhibitor of metalloproteinase-1 moderates airway re-epithelialization by regulating matrilysin activity. Am J Pathol. 2008;172(5):1256–1270.
   PubMed Web of Science ®Google Scholar
• Khokha R, Murthy A, Weiss A. Metalloproteinases and their natural inhibitors in inflammation and immunity. Nat Rev Immunol. 2013;13(9):649–665.
   PubMed Web of Science ®Google Scholar
• Bernardo MM, Fridman R. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP. Biochem J. 2003;374(3):739–745.
   Google Scholar
• Black RA. TIMP3 checks inflammation. Nat Genet. 2004;36(9):934–935.
   PubMed Web of Science ®Google Scholar
• Mohammed FF, Smookler DS, Taylor SEM, et al. Abnormal TNF activity in Timp3 −/− mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet. 2004;36(9):969–977.
   PubMed Web of Science ®Google Scholar
• Borrell-Pagès M, Rojo F, Albanell J, Baselga J, Arribas J. TACE is required for the activation of the EGFR by TGF-α in tumors. Embo J. 2003;22(5):1114–1124.
   PubMed Web of Science ®Google Scholar
• Hamilton LM, Torres-Lozano C, Puddicombe SM, et al. The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma. Clin Exp Allergy. 2003;33(2):233–240.
   PubMed Web of Science ®Google Scholar
• Hashimoto G, Aoki T, Nakamura H, Tanzawa K, Okada Y. Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4). FEBS Lett. 2001;494(3):192–195.
   Web of Science ®Google Scholar
• Troeberg L, Fushimi K, Scilabra SD, et al. The C-terminal domains of ADAMTS-4 and ADAMTS-5 promote association with N-TIMP-3. Matrix Biol. 2009;28(8):463–469.
   PubMed Web of Science ®Google Scholar
• Murphy AN, Unsworth EJ, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol. 1993;157(2):351–358.
   Web of Science ®Google Scholar
• Baker AH, Zaltsman AB, George SJ, Newby AC. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J Clin Invest. 1998;101(6):1478–1487.
   Web of Science ®Google Scholar
• Liu X-W, Bernardo MM, Fridman R, Kim H-RC, H-Rc K. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway. Journal of Biological Chemistry. 2003;278(41):40364–40372.
   Web of Science ®Google Scholar
• Savarin C, Bergmann CC, Hinton DR, Stohlman SA. MMP-independent role of TIMP-1 at the blood brain barrier during viral encephalomyelitis. ASN Neuro. 2013;5(5):AN20130033.
   Web of Science ®Google Scholar
• Qi JH, Ebrahem Q, Moore N, et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med. 2003;9(4):407–415.
   PubMed Web of Science ®Google Scholar
• Qi JH, Anand-Apte B. Tissue inhibitor of metalloproteinase-3 (TIMP3) promotes endothelial apoptosis via a caspase-independent mechanism. Apoptosis. 2015;20(4):523–534.
   Web of Science ®Google Scholar
• Aird WC. Review article the role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. 2003;101(10):3765–3777.
   Google Scholar
• Yazdan-Ashoori P, Liaw P, Toltl L, et al. Elevated plasma matrix metalloproteinases and their tissue inhibitors in patients with severe sepsis. J Crit Care. 2011;26(6):556–565.
   Web of Science ®Google Scholar
• Hästbacka J, Linko R, Tervahartiala T, et al. Serum MMP-8 and TIMP-1 in critically ill patients with acute respiratory failure: TIMP-1 is associated with increased 90-day mortality. Anesth Analg. 2014;118(4):790-8.
   Web of Science ®Google Scholar
• Wang M, Zhang Q, Zhao X, Dong G, Li C. Diagnostic and prognostic value of neutrophil gelatinase-associated lipocalin, matrix metalloproteinase-9, and tissue inhibitor of matrix metalloproteinases-1 for sepsis in the Emergency Department: an observational study. Critical Care. 2014;18(6):634.
   PubMed Web of Science ®Google Scholar
• Lorente L, Martín MM, Solé-Violán J, et al. Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio. PLoS One. 2014;9(4):e94318.
   Web of Science ®Google Scholar
• Bojic S, Kotur-Stevuljevic J, Kalezic N, et al. Diagnostic value of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in sepsis-associated acute kidney injury. Tohoku J Exp Med. 2015;237(2):103–109.
   Web of Science ®Google Scholar
• Mühl D, Nagy B, Woth G, et al. Dynamic changes of matrix metalloproteinases and their tissue inhibitors in severe sepsis. J Crit Care. 2011;26(6):550–555.
   Web of Science ®Google Scholar
• Bugno M, Witek B, Bereta J, Bereta M, Edwards DR, Kordula T. Reprogramming of TIMP-1 and TIMP-3 expression profiles in brain microvascular endothelial cells and astrocytes in response to proinflammatory cytokines. FEBS Lett. 1999;448(1):9–14.
   Web of Science ®Google Scholar
• Shastry S, Tyagi SC. Homocysteine induces metalloproteinase and shedding of β-1 integrin in microvessel endothelial cells. J Cell Biochem. 2004;93(1):207–213.
   Web of Science ®Google Scholar
• Arpino V, Mehta S, Wang L, et al. Tissue inhibitor of metalloproteinases 3-dependent microvascular endothelial cell barrier function is disrupted under septic conditions. American Journal of Physiology-Heart and Circulatory Physiology. 2016;310(11):H1455–H1467.
   Web of Science ®Google Scholar
• Shen Q, Lee ES, Pitts RL, Mh W, Yuan SY. Tissue inhibitor of metalloproteinase-2 regulates matrix metalloproteinase-2–mediated endothelial barrier dysfunction and breast cancer cell transmigration through lung microvascular endothelial cells. Mol Cancer Res. 2010;8(7):939–951.
   Web of Science ®Google Scholar
• Dollery CM, Mcewan JR, Wang M, Sang QA, Liu YE, Shi YE. TIMP-4 is regulated by vascular injury in rats. Circ Res. 1999;84(5):498–504.
   Web of Science ®Google Scholar
• Schrimpf C, Xin C, Campanholle G, et al. Pericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury. J Am Soc Nephrol. 2012;23(5):868–883.
   Web of Science ®Google Scholar
• Schrimpf C, Koppen T, Duffield JS, et al. TIMP3 is regulated by pericytes upon shear stress detection leading to a modified endothelial cell response. Eur J Vasc Endovasc Surg. 2017;54(4):524–533.
   Web of Science ®Google Scholar
• Fujimoto M, Takagi Y, Aoki T, et al. Tissue inhibitor of metalloproteinases protect blood—brain barrier disruption in focal cerebral ischemia. J Cereb Blood Flow Metab. 2008;28(10):1674–1685.
   Web of Science ®Google Scholar
• Chen F, Ohashi N, Li W, Eckman C, Nguyen JH. Disruptions of occludin and claudin-5 in brain endothelial cells in vitro and in brains of mice with acute liver failure. Hepatology. 2009;50(6):1914–1923.
   Web of Science ®Google Scholar
• Menge T, Zhao Y, Zhao J. mesenchymal stem cells regulate blood brain barrier integrity in traumatic brain injury through production of the soluble factor TIMP3. Sci Transl Med. 2012;4(161):161ra150–161161.
   Web of Science ®Google Scholar
• Koskivirta I, Rahkonen O, Mäyränpää M, et al. Tissue inhibitor of metalloproteinases 4 (TIMP4) is involved in inflammatory processes of human cardiovascular pathology. Histochem Cell Biol. 2006;126(3):335–342.
   PubMed Web of Science ®Google Scholar
• Rorive S, Lopez XM, Maris C, et al. TIMP-4 and CD63: new prognostic biomarkers in human astrocytomas. Mod Pathol. 2010;23(10):1418–1428.
   Web of Science ®Google Scholar
• Bauer H, Zweimueller-Mayer J, Steinbacher P, Lametschwandtner A, Bauer HC. The dual role of zonula occludens (ZO) proteins. J Biomed Biotechnol. 2010;2010(4):1–11.
   Google Scholar
• Ichikawa-Tomikawa N, Sugimoto K, Satohisa S, Nishiura K, Chiba H. Possible involvement of tight junctions, extracellular matrix and nuclear receptors in epithelial differentiation. J Biomed Biotechnol. 2011;2011(2):1–10.
   Google Scholar
• Liu J, Jin X, Liu KJ, Liu W. Matrix metalloproteinase-2-mediated occludin degradation and caveolin-1-mediated claudin-5 redistribution contribute to blood-brain barrier damage in early ischemic stroke stage. Journal of Neuroscience. 2012;32(9):3044–3057.
   PubMed Web of Science ®Google Scholar
• Sidibé A, Mannic T, Arboleas M, et al. Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: evidence for tumor necrosis factor α-induced VE-cadherin cleavage. Arthritis Rheum. 2012;64(1):77–87.
   Google Scholar
• Schulz B, Pruessmeyer J, Maretzky T, et al. ADAM10 regulates endothelial permeability and T-cell transmigration by proteolysis of vascular endothelial cadherin. Circ Res. 2008;102(10):1192–1201.
   PubMed Web of Science ®Google Scholar
• Lominadze D, Roberts AM, Tyagi N, Moshal KS, Tyagi SC. Homocysteine causes cerebrovascular leakage in mice. Am J Physiol Heart Circ Physiol. 2006;290(3):H1206–H1213.
   Web of Science ®Google Scholar
• Passi A, Negrini D, Albertini R, de Luca G, Miserocchi G. Involvement of lung interstitial proteoglycans in development of hydraulic- and elastase-induced edema. Am J Physiol Lung Cell Mol Physiol. 1998;275(3):L631–L635.
   Web of Science ®Google Scholar
• Partridge CA, Jeffrey JJ, Malik AB. A 96-kDa gelatinase induced by TNF-alpha contributes to increased microvascular endothelial permeability. Am J Physiol Lung Cell Mol Physiol. 1993;265(5):L438–L447.
   Google Scholar
• Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev. 2006;86(1):279–367.
   PubMed Web of Science ®Google Scholar
• Bruegmann E, Gruemmer R, Neulen J, Motejlek K. Regulation of soluble vascular endothelial growth factor receptor 1 secretion from human endothelial cells by tissue inhibitor of metalloproteinase 1. Mol Hum Reprod. 2009;15(11):749–756.
   Web of Science ®Google Scholar
• Ebrahem Q, Qi JH, Sugimoto M, et al. Increased neovascularization in mice lacking tissue inhibitor of metalloproteinases-3. Invest Ophthalmol Vis Sci. 2011;52(9):6117–6123.
   Web of Science ®Google Scholar
• Lee S-J, Tsang PS, M Diaz T, Wei B-Yang, Stetler-Stevenson WG. TIMP-2 modulates VEGFR-2 phosphorylation and enhances phosphodiesterase activity in endothelial cells. Lab Invest. 2010;90(3):374–382.
   Web of Science ®Google Scholar
• Singh R, Mason J, Lidington E, et al. Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3. Cardiovasc Res. 2005;67(1):39–49.
   Web of Science ®Google Scholar
• Ponnuchamy B, Khalil RA. Role of ADAMs in endothelial cell permeability: cadherin shedding and leukocyte rolling. Circ Res. 2008;102(10):1139–1142.
   PubMed Web of Science ®Google Scholar
• Sithu SD, English WR, Olson P, et al. Membrane-type 1-matrix metalloproteinase regulates intracellular adhesion molecule-1 (ICAM-1)-mediated monocyte transmigration. J Biol Chem. 2007;282(34):25010–25019.
   Web of Science ®Google Scholar
• Garton KJ, Gough PJ, Philalay J, et al. Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17). J Biol Chem. 2003;278(39):37459–37464.
   PubMed Web of Science ®Google Scholar